Beck Bode’s Definium Therapeutics DFTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$226K Hold
5,939
– – 0.04% 89
2026
Q2
$279K Buy
+5,939
New +$147K 0.04% 86

Other funds holding DFTX

Beck Bode's DFTX Position: Q3 2026 in Review

Beck Bode held its Definium Therapeutics (DFTX) position steady in Q3 2026 at 5,939 shares worth $226K. The position accounts for 0.04% of the portfolio, ranked #89.

Beck Bode first reported a position in DFTX in Q2 2026 and has held it in 2 quarters since. The position peaked at $279K in Q2 2026. 253 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.

  • Beck Bode held 5,939 shares of Definium Therapeutics worth $226K as of Q3 2026.
  • Beck Bode left its Definium Therapeutics share count unchanged in Q3 2026.
  • Definium Therapeutics made up 0.04% of Beck Bode's portfolio in Q3 2026, its #89 holding.
  • Beck Bode first reported a position in Definium Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • Beck Bode's Definium Therapeutics position peaked at $279K in Q2 2026.
  • 253 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.

Based on Beck Bode's 13F filing for Q3 2026, filed 12 Nov 2026.